kynurenine and levodopa

kynurenine has been researched along with levodopa in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's2 (22.22)18.2507
2000's1 (11.11)29.6817
2010's4 (44.44)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Baker, H; Gauthier, S; Magnussen, I; Osterland, CK; Sternberg, EM; Van Woert, MH; Young, SN1
Abe, T; Hamato, H; Takahashi, J; Takahashi, S; Tohgi, H1
Achilli, G; Banting, A; Banting, S; Le Bars, D; Weil-Fugazza, J1
Bédard, PJ; Di Paolo, T; Grégoire, L; Guidetti, P; Izzo, E; Rassoulpour, A; Samadi, P; Schwarcz, R1
Gárdián, G; Vécsei, L1
Kincses, ZT; Szabó, N; Toldi, J; Vécsei, L1
Fülöp, F; Majláth, Z; Toldi, J; Vécsei, L1
Andersen, AD; Binzer, M; Blaabjerg, M; Faergeman, NJ; Gramsbergen, JB; Havelund, JF; Heegaard, NHH; Stenager, E1
Asakawa, T; Chen, W; Jia, X; Qin, W; Shi, Y1

Reviews

4 review(s) available for kynurenine and levodopa

ArticleYear
Medical treatment of Parkinson's disease: today and the future.
    International journal of clinical pharmacology and therapeutics, 2010, Volume: 48, Issue:10

    Topics: Dopamine Agonists; Humans; Kynurenine; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease

2010
Altered tryptophan metabolism in Parkinson's disease: a possible novel therapeutic approach.
    Journal of the neurological sciences, 2011, Nov-15, Volume: 310, Issue:1-2

    Topics: Antiparkinson Agents; Humans; Kynurenine; Levodopa; Parkinson Disease; Tryptophan

2011
Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa- Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System.
    Current medicinal chemistry, 2016, Volume: 23, Issue:9

    Topics: Animals; Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Kynurenine; Levodopa; Molecular Structure; Parkinson Disease

2016
Can kynurenine pathway be considered as a next-generation therapeutic target for Parkinson's disease? An update information.
    Bioscience trends, 2022, Sep-17, Volume: 16, Issue:4

    Topics: 3-Hydroxyanthranilic Acid; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Levodopa; Parkinson Disease; Quinolinic Acid; Tryptophan

2022

Trials

1 trial(s) available for kynurenine and levodopa

ArticleYear
Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.
    The New England journal of medicine, 1980, Oct-02, Volume: 303, Issue:14

    Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Carbidopa; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Kynurenine; Levodopa; Male; Middle Aged; Myoclonus; Parkinson Disease; Scleroderma, Systemic; Serotonin

1980

Other Studies

4 other study(ies) available for kynurenine and levodopa

ArticleYear
Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospinal fluid of patients with Parkinson's disease, and their changes after L-dopa administration.
    Neuroscience letters, 1993, Sep-03, Volume: 159, Issue:1-2

    Topics: Aged; Dopamine; Humans; Hydroxyindoleacetic Acid; Kynurenine; Levodopa; Middle Aged; Parkinson Disease; Psychometrics; Serotonin

1993
Tyrosine and tryptophan derivatives in pig lumbar cerebrospinal fluid. Effects of subchronic administration of dopa associated with benserazide.
    Advances in experimental medicine and biology, 1996, Volume: 398

    Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Oral; Animals; Benserazide; Drug Interactions; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Kynurenine; Levodopa; Male; Methoxyhydroxyphenylglycol; Normetanephrine; Swine; Tryptamines; Tryptophan; Tyrosine

1996
Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys.
    Behavioural brain research, 2008, Jan-25, Volume: 186, Issue:2

    Topics: Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Drug Interactions; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Female; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Levodopa; Macaca fascicularis; Motor Activity; Parkinsonian Disorders; Quinolinic Acid; Sulfonamides; Thiazoles; Time Factors

2008
Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia.
    Journal of neurochemistry, 2017, Volume: 142, Issue:5

    Topics: Adult; Aged; Antiparkinson Agents; Biomarkers; Denmark; Dyskinesia, Drug-Induced; Female; Humans; Kynurenine; Levodopa; Male; Middle Aged; Parkinson Disease; Signal Transduction; Single-Blind Method

2017